NAYA Biosciences Inc. Com...

NASDAQ: IVF · Real-Time Price · USD
1.56
-0.19 (-10.86%)
At close: Aug 15, 2025, 3:59 PM
1.59
1.90%
After-hours: Aug 15, 2025, 07:58 PM EDT

NAYA Biosciences Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.59M 6.53M 6.23M 5.77M 4.25M 3.02M 1.92M 1.18M 1.01M 822.2K 3.59M 3.58M 3.64M 4.16M 1.31M 1.43M 1.46M
Cost of Revenue
3.85M 3.66M 3.59M 3.18M 2.55M 1.93M 1.13M 794.89K 751.78K 585.74K 553.84K 325.28K 147.27K 145.05K 107.96K 114.94K 121.51K
Gross Profit
2.74M 2.87M 2.64M 2.59M 1.7M 1.09M 790.08K 382.5K 255.84K 236.46K 3.04M 3.25M 3.49M 4.02M 1.2M 1.31M 1.34M
Operating Income
-24.29M -8.13M -5.66M -5.24M -5.41M -6.77M -7.98M -9.62M -10.23M -10.63M -7.4M -7.15M -6.36M -5.22M -7.51M -6.5M -5.68M
Interest Income
n/a n/a n/a n/a n/a n/a 1.00 35.00 83.00 308.00 369.00 335.00 2.71K 4.5K 4.44K 4.44K 2.01K
Pretax Income
-24.93M -9.12M -7.41M -7.06M -7.05M -8.01M -8.8M -10.1M -10.67M -10.89M -8.02M -7.95M -6.97M -6.65M -10.56M -9.85M -9.36M
Net Income
-24.9M -9.1M -7.47M -7.08M -7.08M -8.03M -8.81M -10.11M -10.67M -10.89M -8.27M -7.96M -6.98M -6.65M -10.32M -9.85M -9.36M
Selling & General & Admin
10.19M 9.08M 7.46M 7.2M 6.6M 7.49M 8.47M 9.53M 9.94M 10.3M 9.89M 9.99M 9.59M 9.02M 8.33M 7.38M 6.59M
Research & Development
750.44K 489.66K 10.79K 13.46K 97.31K 165.94K 233.87K 406.47K 513.38K 544.04K 533.96K 414.09K 254.34K 216.43K 373.61K 430.77K 434.64K
Other Expenses
16.08M 1.43M 829.39K 619.4K 408.77K 200.89K 59.3K 58.52K 38.82K 19.73K 19.73K n/a n/a n/a n/a n/a n/a
Operating Expenses
27.03M 11M 8.3M 7.83M 7.1M 7.85M 8.77M 10M 10.49M 10.86M 10.44M 10.4M 9.85M 9.23M 8.71M 7.81M 7.02M
Interest Expense
1.19M 1.06M 1.01M 1.09M 890.62K 925.91K 799.99K 449.67K 274.58K 59.45K 189.78K 281.41K 372.43K 1.27M 3.1M 3.52M 3.68M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
30.88M 14.66M 11.89M 11.01M 9.66M 9.79M 9.89M 10.79M 11.24M 11.45M 11M 10.73M 10M 9.38M 8.82M 7.93M 7.14M
Income Tax Expense
-24.75K -22.91K 54.13K 26.76K 29.62K 27.79K 6.82K 4.94K 2.87K 2.87K 800.00 800.00 n/a n/a 36.00 36.00 36.00
Shares Outstanding (Basic)
1.39M 401.01K 323.83K 300.82K 316.82K 218.04K 148.07K 61.02K 51.88K 51.19K 50.65K 50.48K 50.21K 47.26K 43.6K 43.52K 41.2K
Shares Outstanding (Diluted)
1.39M 401.01K 323.83K 300.82K 316.82K 218.04K 148.07K 61.02K 51.88K 51.19K 50.65K 50.48K 50.21K 47.26K 43.6K 43.52K 41.2K
EPS (Basic)
-34.05 -26.56 -26.67 -30.03 -59.31 -103.47 -148.37 -190.25 -208.97 -214.97 -163.91 -171.23 -156.59 -161.39 -277.27 -305.51 -329.01
EPS (Diluted)
-34.05 -26.56 -26.67 -30.03 -59.31 -103.47 -148.37 -190.25 -208.97 -214.97 -163.91 -171.23 -156.59 -161.39 -277.27 -305.51 -329.01
EBITDA
-22.81M -7.14M -5.58M -5.35M -5.75M -6.88M -7.86M -9.52M -10.28M -10.66M -7.66M -7.47M -6.37M -5.22M -7.36M -6.28M -5.64M
EBIT
-23.74M -8.06M -6.41M -5.97M -6.16M -7.08M -8M -9.65M -10.39M -10.83M -7.83M -7.67M -6.6M -5.38M -7.46M -6.34M -5.67M
Depreciation & Amortization
927.11K 919.6K 829.39K 619.4K 408.77K 200.89K 136.85K 136.08K 81.56K 134.91K 136.72K 163.4K 229.87K 166.08K 95.34K 57.73K 34.63K